divendres, 30 de maig del 2014

Valeant raises bid to $53B for Allergan




Valeant Pharmaceuticals boosts its unsolicited acquisition offer for Allergan to $53.3 billion, hoping to win shareholders with a steep premium.





Valeant now willing to pay $53B for Allergan

Pershing Capital Management, Valeant Pharmaceuticals, Allergan Inc.

News Well, Cosmetic/Aesthetic, Mergers & Acquisitions, Pharmaceuticals

read more






from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1o8xirb
Publicat per a
Etiquetes de comentaris: ,

Cap comentari:

Publica un comentari a l'entrada

Subscriure's a: Comentaris del missatge (Atom)